Form 6-K INNEOVA Holdings Ltd For: Jun 10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

Commission File Number 001-42381

 

INNEOVA Holdings Limited

(Exact name of registrant as specified in its charter)

 

Not Applicable

(Translation of Registrant’s Name into English)

 

14 Ang Mo Kio Street 63, Singapore		569116
(Address of principal executive offices)		(Zip Code)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

 

Yes ☐ No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 

 

 

Nasdaq Extension Letter regarding Minimum Bid Price Deficiency

 

As was reported on a Form 6-K filed on December 11, 2025, INNEOVA Holdings Limited (the “Company”) received a letter on December 8, 2025 from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from October 24, 2025 to December 5, 2025, the Company no longer met the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq provided the Company with a 180-calendar day compliance period, or until June 8, 2026, in which to regain compliance with Nasdaq continued listing requirement.

 

The Company did not regain compliance by Jume 8, 2026 and requested an extension. Nasdaq provided the Company with an additional 180 calendar days to meet the bid price requirement as the Company provided written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary.

 

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.

 

On June 10, 2026, the Company issued a press release discussing the receipt of the extension letter, which is filed as exhibit 99.1 to this Form 6-K.

 

Exhibits

 

99.1

Press Release on Extension Grant dated June 10, 2026

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: June 10, 2026
/s/ Chin Heng Neo
Chin Heng Neo, Chief Executive Officer and Executive Director

 

 

ATTACHMENTS / EXHIBITS

EX-99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Medbridge and Patient360 Partner to Help Practices Protect Medicare Reimbursement
• American Kidney Fund Activates Disaster Relief Program to Provide Aid to Dialysis and Post-Transplant Patients in Washington State Affected by Wildfires
• BQE's 2026 A&E Benchmarking Reports Reveal Which Metrics Actually Predict Firm Performance